Dr Andreea Fainarea

 

MEDIC SPECIALIST PSIHIATRU

Membru al Colegiului Medicilor din Romania

 

 

Experienta profesionala in managementul patologiei psihiatrice a adultului , în terapia farmacologica a patologiei psiho-organice, în tratamentul urgentelor psihiatrice pe baza implicarii in asigurarea serviciului de garda in spitale de psihiatrie

 

 

Domenii de interes

  • abordarea psihofarmacologica si psihoterapeutica a disfunctiilor sexuale
  • terapia de preventie a recaderilor in cazul pacientilor cu adictii de substanta si comportamentale
  • aplicarea si monitorizarea terapiilor farmacologice de ultima generatie pentru tulburarea depresiva majora rezistenta la tratament
  • managementul tulburarii de personalitate borderline

 

Educatie si formare

2014: Absolventa a Facultatii de Medicina Generala din cadrul Universitatii de Medicina si Farmacie “Carol Davila” –Bucuresti

2015-2020: Medic rezident Psihiatrie in cadrul Spitalului Universitar de Urgenta Militar Centra “ Dr. Carol Davila “ , Bucuresti

Oct. 2020: Medic specialist Psihiatrie

Dec. 2020 –prezent: Medic specialist Psihiatrie -Clinica Hope, Bucuresti

Feb.2021 –prezent: Medic specialist Psihiatrie – Linie de Garda –SUUMC “DR. Carol Davila “, Bucuresti

 

Workshop-uri

ECNP Workshop for Junior Scientists in Europe; 9-12 Mar 2017, Nice, France

dr andreea fainarea

Lucrari publicate la care am participat

 

  •  Calcium channel alpha-2-delta ligands as add-on strategy to antidepressants in generalized anxiety disorder and major depressive disorder dual diagnosis. 33rd ECNP Congress. European Neuropsychopharmacology 2020;40(Suppl.1):S372-353.
  • Immune-modulation therapy for depressive disorders. 28th European Congress of Psychiatry. European Psychiatry 2020; 63(Suppl.1):S369.
  • Placebo response in clinical trials- how to decrease its negative impact?. 28th European Congress of Psychiatry. European Psychiatry 2020; 63(Suppl.1):S519.
  • New pharmacological approaches for binge-eating disorder. Carol Davila University Central Emergency Military Hospital Scientific Days, 9th Ed., Romanian Journal of Military Medicine 2019; CXXII (Suppl.1):15-16.
  • Effectiveness of  the pharmacological approach in preventing post-stroke depression. ECNP Workshop for Early Career Scientists in Europe. European Neuropsychopharmacology 2019;Vol 29 (Suppl):2
  • The role of microbiome in schizophrenia – a literature review. The ”Dr. Carol Davila” Central Military University Emergency Hospital Annual Conference-8th edition, Bucharest, 2018.
  • Algorithm  for evaluation of the quality of life in caregivers of patients diagnosed with Alzheimer neurocognitive disorder. 26th European Congress of Psychiatry. European Psychiatry 2018;vol.48(Suppl.1):S205.
  • Pharmacological management of late-onset schizophrenia-a case series. 31st ECNP Congress 2018; Final Programme:113: EP.1002.
  • Combined pharmacological treatment for alchohol dependence-review of current evidence and new study project. 31st ECNP Congress 2018; Final Programme:113: EP.1003.
  • Analysis of risk factors in antipsychotic-resistant schizophrenia in young patients- a retrospective analysis. Romanian Journal of Military Medicine 2018; Vol CXXI (Suppl):1.
  • Vagus nerve stimulation in Alzheimer Dementia and in patients with risk for developing neurocognitive disorders- A literature review. WPA Thematic Congress 2018:EP07.
  • The gut microbiota modification as a therapeutic strategy for psychiatric disorders- A review of the available data. WPA Thematic Congress 2018:SC17.
  • Project for an Internet-based anti-stigmatization platform dedicated to patients diagnosed with schizophrenia. WPA Thematic Congress 2018:SC24.
  • New therapeutical means for schizofrenia-focus on the deep brain  stimulation. A XI-a Conferință Națională de Psihiatrie Biologică și Psihofarmacologică. Romanian Journal of Psychiatry 2018;XX(1):5.
  • Comparative analysis of bupropion, nicotine replacement therapy and combined treatment in adults with tobacco use disorder. European Neuropsychopharmacology Neurocience Applied 2017; vol.27 (Suppl 1):P .4.001.
  • Comparative efficacy analysis of naltrexone and selective serotonin reuptake inhibitors in pathological gambling treatment. European Neuropsychopharmacology Neurocience Applied 2017; vol.27 (Suppl 1):P .4.002.
  • Recommendations for long acting injectable antipsychotics in patients with schizophrenia. The 10th National Conference of Biological Psychiatry and Psychopharmacology. Romanian Journal of Psychopharmacology 2017;17(1):O16.
  • Quetiapine XR as add-on to antidepressants in treatment-resistant late-life major depression. European Psychiatry 2017; vol.41, pp.S1-S910, EW0116.
  • Pharmacological management of antipsychotic-induced obesity- a systematic literature review.  30th ECNP Congress; European Neuropsychopharmacology Neuroscience Applied 2017; P.3.d.002.
  • Evaluation of cognitive functioning during antidepressant treatment in young patients with severe major depressive disorder. European Neuropsychopharmacology Neuroscience Applied 2017; vol.25 (Suppl.1):P.3.017.
  • Therapeutic management of obesity in patients who gained weight during antidepressant treatment. 29th  ECNP Congress. European Neuropsychopharmacology 2016;26(Suppl.2):S475-476.
  • Improving treatment adherence in schizophrenia diagnosed patients by using long acting injectable antipsychotics. Carol Davila University Central Emergency Military Hospital Scientific Days, 6th  Ed. Romanian Journal of Military Medicine 2016; vol.CXIX(Suppl.):5.

 

Programeaza-te la Dr Andreea Fainarea

Suna chiar acum

Colegele noastre te vor ajuta sa-ti faci o programare cat mai potrivita pentru tine.

Nu poti vorbi acum?

Preferi sa ne scrii?

Completeaza formularul de mai jos.

    Programeaza-te
    Call Now ButtonPROGRAMEAZA-TE